Daniel M Junius insider trades

Open-market stock purchases and sales by Daniel M Junius, Director at Idexx Laboratories Inc /DE, from SEC Form 4 filings since Jul 23, 2010.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +161%.

Recent trades

DateStockTradeValue
May 12, 2026IDXX Idexx Laboratories Inc /DEBought (not open market)—
May 12, 2026IDXX Idexx Laboratories Inc /DEBought (not open market)—
May 7, 2026IDXX Idexx Laboratories Inc /DEBought (not open market)—

Companies traded

  • IDXX Idexx Laboratories Inc /DE: 1 buy, 11 sales, last May 12, 2026
  • GLYC Glycomimetics Inc: 5 buys, last May 1, 2024
  • IMGN Immunogen Inc: 19 sales, last Mar 16, 2018
  • VTAE Vitae Pharmaceuticals, Inc: other filings, last Oct 25, 2016

Get free alerts when Daniel M Junius files a new trade →